Prestige Consumer Healthcare (PBH) FY2019 results: revenue $976 million, down 6.3% on the year
Prestige Consumer Healthcare Inc. (PBH) reported revenue of $976 million for fiscal 2019, the year ended 31 March 2019, down 6.3% on the year before. Net income was -$36 million, and diluted earnings per share $-0.69. The figures are the company's own, from the 10-K it filed with the SEC on 13 May 2019.
Revenue
$976 million
-6.3% on the year
FY2012FY2019
Operating margin
6.9%
20.7% a year earlier
FY2012FY2019
Net income
-$36 million
FY2012FY2019
Diluted EPS
-$0.69
FY2012FY2019
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Revenue
976
1,041
882
-6.3%
Cost of revenue
420
465
382
-9.6%
Gross profit
556
577
500
-3.6%
Gross margin
56.9%
55.4%
56.7%
Operating income
67.5
216
206
-68.7%
Operating margin
6.9%
20.7%
23.3%
Interest expense
105
106
93.5
-1.1%
Pre-tax income
-38.1
107
111
Income tax
-2.3
-232
41.5
Effective tax rate
n/a
-217.1%
37.4%
Net income
-35.8
340
69.4
Net margin
-3.7%
32.6%
7.9%
Diluted EPS
-$0.69
$6.34
$1.30
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Operating cash flow
189
210
149
-9.9%
Capital expenditure
10.5
12.5
3.0
-16.4%
Free cash flow
179
198
146
-9.5%
Free cash flow margin
18.3%
19.0%
16.5%
Cash from investing
55.4
-11.6
-695
Cash from financing
-249
-209
562
Depreciation and amortisation
31.8
33.4
25.8
-4.9%
Share-based compensation
7.4
8.9
8.1
-16.5%
Buybacks
50.0
0.0
0.0
Diluted shares, weighted
52m
54m
53m
-2.7%
Balance sheet
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Shareholders' equity
1,096
1,179
823
-7.0%
Debt
1,799
1,993
2,194
-9.8%
Operating lease liabilities
0.0
n/a
n/a
Finance lease liabilities
0.0
n/a
n/a
Other liabilities
547
589
895
-7.2%
Total liabilities and equity
3,441
3,761
3,911
-8.5%
Fixed assets
51.2
52.6
50.6
-2.6%
Goodwill
579
620
615
-6.7%
Intangible assets
2,507
2,781
2,904
-9.8%
Cash and equivalents
27.5
32.5
41.9
-15.4%
Receivables
149
141
137
+5.6%
Inventory
120
119
116
+1.1%
Other assets
7.9
15.1
47.7
-47.8%
Total assets
3,441
3,761
3,911
-8.5%
10-K for the year ended 31 March 2019, filed 13 May 2019: the filing.